Method for determining analyte concentration using periodic temperature modulation and phase detection

• US 6,161,028 A
• Filed: 03/10/1999
• Issued: 12/12/2000
• Est. Priority Date: 03/10/1999
• Status: Expired due to Fees

• Current Assignee: OptiScan Biomedical Corporation
• Original Assignee: OptiScan Biomedical Corporation
• Inventors: Kramer, Charles E., Braig, James R., Zheng, Peng, Sterling, Bernhard B., Shulenberger, Arthur M., Goldberger, Daniel S., King, Richard A., Trebino, Rick, Barnes, Casper W.
• Primary Examiner(s): WINAKUR, ERIC FRANK
• Application Number:
  US09/267,121
• Time in Patent Office: 643 Days
• Field of Search: 600/309, 600/310, 600/316, 600/322, 600/365, 600/473, 600/474, 250/341.6, 250/341.1, 250/341.5, 250/339.07, 250/339.09, 250/339.03, 250/339.04, 250/339.05, 250/339.12
• US Class Current: 600/316
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence
• CPC Class Codes: G01N 21/35 using infrared light G01N21/39 takes precedence

Abstract

A method of determining the analyte concentration of a test sample is described. A temperature gradient is introduced in the test sample and infrared radiation detectors measure radiation at selected analyte absorbance peak and reference wavelengths. Reference and analytical signals are detected. In the presence of the selected analyte, parameter differences between reference and analytical signals are detectable. These parameter differences, having a relationship to analyte concentration, are measured, correlated, and processed to determine analyte concentration in the test sample. Accuracy is enhanced by inducing a periodically modulated temperature gradient in the test sample. The analytical and reference signals may be measured continuously and the parameter difference integrated over the measurement period to determine analyte concentration.

Claims

1. A method of analyzing a test sample, comprising the steps of:

a) providing a test sample;

b) inducing a thermal gradient in said test sample;

c) responsive to said inducing step, measuring a reference signal emitted by said sample;

d) further responsive to said inducing step, measuring an analytical signal emitted by said sample;

e) comparing said reference and analytical signals to determine phase difference information between said reference and analytical signals to determine parameter information; and

f) transmitting said parameter information, as an electrical signal for processing.

2. A method as in claim 1, wherein said step of comparing phase difference information includes the step of deducing the analyte concentration of said sample based on said phase difference information.

3. A method as in claim 2, wherein said step of deducing the analyte concentration includes correlating said phase information with known information regarding analyte concentration and phase.

4. A method as recited in claim 2, wherein at least one of said signals is measured at a predefined wavelength interval defined by analyte absorbance peaks.

5. A method as in claim 1, wherein said analytical signal is measured at a predefined wavelength.

6. A method as in claim 1, wherein said reference signal is measured at a predefined wavelength.

7. A method as in claim 6, wherein said predefined wavelength is defined by one or more absorbance properties of the sample media.

8. A method as in claim 1 wherein said step of inducing a thermal gradient in said test sample includes inducing a periodic thermal gradient in said test sample.

9. A method of spectroscopically analyzing a test sample, comprising the steps of:

a) providing a test sample;

b) inducing a thermal gradient in said test sample;

c) responsive to said inducing step, measuring a reference signal emitted by s aid sample;

d) further responsive to said inducing step, measuring an analytical signal emitted by said sample;

e) comparing said measured reference and said analytical signal s to determine phase difference information between said analytical and reference signals;

f) using the magnitude of said phase difference to determine sample analyte concentration information; and

g) transmitting said concentration information, as an electrical signal for processing.

10. A method as in claim 9 wherein said step of inducing a thermal gradient in said test sample comprises inducing and maintaining a periodically modulated thermal gradient in said test sample over a test period.

11. A method as in claim 10 wherein said step of comparing said measured reference and analytical signals includes making continuous measurements of said phase difference during the test period.

12. A method of determining the absolute or relative concentration of a chemical analyte in a medium, said method comprising the steps of:

a) inducing a periodically modulated thermal gradient into said medium;

b) responsive to said inducing step, measuring the radiation emitted from said medium at a pre-determined wavelength related to said analyte, resulting in an analytical signal;

c) further responsive to said inducing step, measuring the radiation emitted from said medium at a reference wavelength, resulting in a reference signal;

d) comparing the analytical signal with at least one of said reference signal;

e) determining from said comparison, the phase difference between said analytical signal and said reference signal to produce a phase signal; and

f) deducing from said phase signal the concentration of said analytes in said medium.

13. A method as in claim 12 wherein said medium is a biological material.

14. A method as in claim 12 wherein said medium is comprised of heterogeneous material.

15. A method as in claim 12 wherein the determination of absolute or relative concentration of a chemical analyte in said medium comprises a non-invasive determination of the analyte concentration.

16. A method as in claim 12 where the chemical analyte to be determined is selected from the group consisting of glucose, insulin, water, carbon dioxide, alcohol, blood oxygen, cholesterol, bilirubin, ketones, fatty acids, lipoproteins, albumin, urea, creatinine, white blood cells, red blood cells, hemoglobin, oxygenated hemoglobin, carboxyhemoglobin, organic molecules, inorganic molecules, pharmaceuticals, cytochrome, various proteins and chromophores, microcalcifications, and hormones.

17. A method as in claim 12 wherein said step of measuring the radiation emitted from said medium at a pre-determined wavelength related to said analyte is measured at an infrared radiation absorbance peak of said analyte.

18. A method as in claim 12 wherein said radiation emitted from said medium at said reference wavelength is measured at a wavelength defined by one or more infrared radiation absorbance peaks of said analyte.

19. A method as in claim 12 wherein said radiation emitted from said medium at said reference wavelength is measured at a wavelength where the infrared radiation absorbance of said medium is high.

20. A method as in claim 12 wherein said radiation emitted from said medium at said reference wavelength is measured at a wavelength where the infrared radiation transmission of said medium is high.

21. A method as in claim 12 wherein said step of inducing a periodically modulated thermal gradient into said medium comprises inducing the periodic gradient at a single driving frequency.

22. A method as in claim 12 wherein said step of inducing a periodically modulated thermal gradient into said medium comprises inducing two periodic gradients at two different driving frequencies.

23. A method as in claim 12 wherein said step of comparing the analytical signal with said reference signal includes continuously comparing said signals over a measurement period.

24. A method as in claim 12 wherein said step of comparing the analytical signal with said reference signal includes intermittently comparing said signals over a measurement period.

25. A method as in claim 12, wherein each of said analytical and reference signals have zero-crossings and wherein said step of comparing the analytical signal with said reference signal includes comparing said analytical signal and said reference signal at their respective zero-crossings.

26. A method of determining the absolute or relative concentration of a chemical analyte in a medium, said method comprising the steps of:

a) inducing a shallow temperature gradient in said medium using a first driving frequency;

b) inducing a deep temperature gradient in said medium using a second driving frequency;

c) responsive to said step of inducing a shallow temperature gradient, measuring a shallow analytical signal and at least one shallow reference signal;

d) responsive to said step of inducing a deep temperature gradient, measuring a deep analytical signal and at least one deep reference signal;

e) comparing the shallow analytical signal with said at least one shallow reference signal;

f) comparing the deep analytical signal with said at least one deep reference signal;

g) determining from the comparison of said shallow signals, a parameter difference between said shallow analytical signal and said at least one shallow reference signal to produce at least one shallow parameter difference signal;

h) determining from the comparison of said deep signals, the parameter difference between said deep analytical signal and said at least one deep reference signal to produce at least one deep parameter difference signal;

i) analyzing said at least one shallow parameter difference signal together with said at least one deep parameter difference signal to determine a combined parameter difference signal; and

j) deducing from said combined parameter difference signal, the concentration of said analytes in said medium.

27. A method as in claim 26 wherein said parameter difference includes a phase difference.

28. A method of determining the absolute or relative concentration of blood glucose in a human or animal subject, said method comprising the steps of:

a) providing a human or animal test subject;

b) inducing two periodic thermal gradients in the skin of said test subject, a first gradient being driven at a first frequency and a second gradient being driven at a second frequency, said second gradient driving frequency being greater than said first gradient driving frequency;

c) responsive to said inducing of the first gradient, measuring the radiation emitted from the deeper regions of the skin at a glucose absorbance peak wavelength, resulting in a first analytical signal at a first reference wavelength, resulting in a first reference signal;

d) responsive to said inducing of the second gradient, measuring the radiation emitted from the shallower regions of the skin at a glucose absorbance peak wavelength, resulting in a second analytical signal at a second reference wavelength, resulting in a second reference signal;

e) comparing said first analytical signal with said first reference signal to determine a phase difference between said first analytical signal and said first reference signal producing a first phase signal;

f) comparing the second analytical signal with said second reference signal to determine a phase difference between said second analytical signal and said second reference signal producing a second phase signal;

g) analyzing said first phase signal together with said second phase signal to determine a combined phase signal;

j) deducing from said combined phase signal, the blood glucose concentration in said test subject; and

k) transmitting said blood glucose concentration information, as an electrical signal, for processing.

29. A method as in claim 28 wherein said first gradient driving frequency is at about 1 hertz and said second gradient driving frequency is at about 3 hertz.

30. A method as in claim 28 wherein said first and second phase signals are sequentially implemented resulting in an alternating frequency pattern in said combined phase signal.

31. A method as in claim 28 wherein said first and second phase signals are implemented simultaneously resulting in said first and second phase signals being superimposed in said combined phase signal.

32. A method as in claim 28 wherein said step of measuring the radiation emitted from the deeper regions of the skin at said first reference wavelength comprises measuring the radiation at wavelengths which bracket said glucose absorbance peak wavelength.

33. A method as in claim 28 wherein said step of measuring the radiation emitted from the deeper regions of the skin at said first reference wavelength comprises measuring the radiation at a wavelength which is near said glucose absorbance peak wavelength.

34. A method as in claim 28 wherein said step of measuring the radiation emitted from the deeper regions of the skin at said first reference wavelength comprises measuring the radiation at a wavelength where the infrared radiation absorbance of the skin is high.

35. A method as in claim 34 wherein said radiation is measured in the range of about 2.2 μ

m to about 3.8 μ

m.

36. A method as in claim 34 wherein said radiation is measured in the range of about 5.5 μ

m to about 6.5 μ

m.

37. A method as in claim 28 wherein said step of measuring the radiation emitted from the deeper regions of the skin at said first reference wavelength comprises measuring the radiation at a wavelength where the infrared radiation transmission of said medium is high.

38. A method as in claim 37 wherein said radiation is measured in the range of about 3.8 μ

m to about 4.8 μ

m.

39. A method as in claim 37 wherein said radiation is measured in the range of about 7 μ

m to about 11 μ

m.

40. A method as in claim 28 wherein said step of measuring the radiation emitted from the shallower regions of the skin at said second reference wavelength comprises measuring the radiation at wavelengths which bracket said glucose absorbance peak wavelength.

41. A method as in claim 28 wherein said step of measuring the radiation emitted from the shallower regions of the skin at said second reference wavelength comprises measuring the radiation at a wavelength which is near said glucose absorbance peak wavelength.

42. A method as in claim 28 wherein said step of measuring the radiation emitted from the shallower regions of the skin at said second reference wavelength comprises measuring the radiation at a wavelength where the infrared radiation absorbance of the skin is high.

43. A method as in claim 42 wherein said radiation is measured in the range of about 2.2 μ

m to about 3.8 μ

m.

44. A method as in claim 42 wherein said radiation is measured in the range of about 5.5 μ

m to about 6.5 μ

m.

45. A method as in claim 28 wherein said step of measuring the radiation emitted from the shallower regions of the skin at said second reference wavelength comprises measuring the radiation at a wavelength where the infrared radiation transmission of said medium is high.

46. A method as in claim 45 wherein said radiation is measured in the range of about 3.8 μ

m to about 4.8 μ

m.

47. A method as in claim 45 wherein said radiation is measured in the range of about 7 μ

m to about 11 μ

m.